Wang A, Chen M, Li D, Shi J, et al. Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study. Clin Genitourin Cancer 2024;22:102085.
PMID: 38636170